中国心脏二尖瓣生物瓣毁损介入瓣中瓣技术多中心专家建议  

Multicenter expert recommendations on interventional valve-in-valve technology for mitral bioprosthetic valve destruction in China

作　　者：张海波[1] 潘湘斌[2] 郭应强[3] 魏来[4] 杨剑 周达新[6] 吴永健[7] 孟旭[1] 刘立明[8] 中国研究型医院学会心脏瓣膜病学专委会 亚洲心脏瓣膜学会中国分会 ZHANG Haibo;PAN Xiangbin;GUO Yingqiang;WEI Lai;YANG Jian;ZHOU Daxin;WU Yongjian;MENG Xu;LIU Liming;Chinese Research Hospital Association(CRHA)Heart Valve Disease Professional Committee;Asian Association for Heart Valve Disease(AAHVD)China Chapter(Valve Surgery Center,Beijing Anzhen Hospital,Capital Medical University,Beijing,100029,P.R.China;Structural Heart Disease Center,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,P.R.China;Department of Cardiovascular Surgery,West China Hospital of Sichuan University,Chengdu,610041,P.R.China;Department of Cardiac Surgery,Zhongshan Hospital,Fudan University,Shanghai,200032,P.R.China;Department of Cardiovascular Surgery,Xijing Hospital,Air Force Medical University,Xi'an,710032,P.R.China;Department of Cardiology,Zhongshan Hospital,Fudan University,Shanghai,200032,P.R.China;Department of Cardiac Surgery,Fuwai Hospital,National Center for Cardiovascular Disease,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,P.R.China;The Second Xiangya Hospital of Central South University,Changsha,410011,P.R.China;不详)

机构地区：[1]首都医科大学附属北京安贞医院瓣膜外科中心,北京100029 [2]中国医学科学院北京协和医学院国家心血管病中心阜外医院结构性心脏病中心,北京100037 [3]四川大学华西医院心脏大血管外科,成都610041 [4]复旦大学附属中山医院心脏外科,上海200032 [5]空军军医大学西京医院心血管外科,西安710032 [6]复旦大学附属中山医院心脏内科,上海200032 [7]中国医学科学院北京协和医学院国家心血管病中心阜外医院心内科,北京100037 [8]中南大学湘雅二医院心血管外科,长沙410011 [9]不详

出　　处：《中国胸心血管外科临床杂志》2024年第8期1090-1095,共6页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

基　　金：首都发展基金项目(2020-2-2065);国家科技部重点专项(2020YFC2008105)。

摘　　要：心脏二尖瓣置换是我国心脏瓣膜最常见的手术之一,近年来随着瓣膜疾病退行性病变增多和患者基础年龄增大以及生物瓣抗钙化技术进步,心脏二尖瓣生物瓣置换比例逐年增加。传统的二尖瓣生物瓣毁损之后需要再次开胸二次换瓣手术,但是心脏和胸骨粘连以及体外循环和心脏停跳导致的损伤对老年和多器官功能不全的患者创伤较大,死亡率和并发症发生率明显升高。近年介入瓣膜手术,特别是瓣中瓣介入手术发展很快,心脏跳动下完成对毁损二尖瓣功能的矫治,但其技术流程与常规的主动脉瓣置换手术存在较多差异,因此我们组织撰写二尖瓣生物瓣毁损的介入瓣中瓣技术流程的多中心专家建议,对于此项技术的培训和推广具有较大意义。Mitral valve replacement is one of the most common heart valve surgeries in China.In recent years,with the increase in degenerative valve diseases,older patients,and the progress of anti-calcification technology of biological valves,the proportion of mitral valve biological valve replacement has been increasing year by year.After the damage of traditional mitral valve biological valves,re-operation of valve replacement with thoracotomy is required.However,the adhesion between the heart and sternum,as well as the damage caused by cardiopulmonary bypass and cardiac arrest,can cause significant trauma to elderly patients and those with multiple organ dysfunction,leading to increased mortality and complication rates.In recent years,interventional valve surgery,especially transcatheter valve-invalve surgery,has developed rapidly.This procedure can correct the damaged mitral valve function without stopping the heart,but there are still many differences between its technical process and conventional aortic valve replacement surgery.Therefore,organizing and writing multicenter expert recommendations on the technical process of transcatheter valve-invalve surgery for damaged mitral valve biological valves is of great significance for the training and promotion of this technology.

关 键 词：二尖瓣生物瓣毁损 介入瓣中瓣 专家建议 

分 类 号：R654.2[医药卫生—外科学]